Dr. Helen H. Cappuccino, MD

Dr. Cappuccino practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Cappuccino's NPI, 1467458893, was assigned on June 21, 2005. Dr. Cappuccino graduated from State University of New York at Buffalo School of Medicine in 1988. Dr. Cappuccino holds New York license 193586.

Dr. Cappuccino's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Cappuccino's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Cappuccino is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Breast Care of Western New York. Dmand AI also links Dr. Cappuccino to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cappuccino practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Cappuccino's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Cappuccino is licensed in New York.

CMS data shows 68 Medicare services from Dr. Cappuccino across 4 procedure codes in 2024, for 39 Medicare patients. Medicare paid $12,003 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Cappuccino in 2024. The largest group is 75 to 84, with 18 patients. 75% of them have cancer, and 74% have high cholesterol. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cappuccino's median patient age at 69, with 95% women.

In 2024, Dr. Cappuccino wrote 31 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $137 in total drug cost. In 2020, CMS named 14 claims across 1 drug.

Dr. Cappuccino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 60 procedures of mastectomy by Dr. Cappuccino, more than 96% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Cappuccino, published from 2015 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Cervical Vertebrae and Hypothermia, Induced. Dr. Cappuccino's most frequent co-authors are Stephen B. Edge, MD, Kazuaki Takabe, MD, PhD and Andrew G. Cappuccino, MD.

Dmand AI links Dr. Cappuccino to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 115 general payments to Dr. Cappuccino from 4 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Merck Sharp & Dohme Corporation paid the most, $68,661.

Dr. Cappuccino graduated from State University of New York at Buffalo School of Medicine in 1988.